Mega-retailer Walmart's shares drop after the company issued fiscal 2026 guidance below analyst expectations. Retail investor darling Palantir Technologies adds to Wednesday's declines following reports of Pentagon cuts and CEO's trading plan.

Molina Healthcare's MOH short percent of float has fallen 8.77% since its last report. The company recently reported that it has 1.04 million shares sold short, which is 2.08% of all regular shares that are available for trading.

O'Reilly Automotive's ORLY short percent of float has risen 14.86% since its last report. The company recently reported that it has 974 thousand shares sold short, which is 1.7% of all regular shares that are available for trading.

Sun Communities's SUI short percent of float has risen 4.98% since its last report. The company recently reported that it has 2.60 million shares sold short, which is 2.74% of all regular shares that are available for trading.

Investors with a lot of money to spend have taken a bullish stance on ON Semiconductor ON. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Q4 revenue hit $502.36 million, exceeding the $486.21 million consensus, with an 8.7% same-unit revenue increase. Adjusted EPS rose to 51 cents, beating the 37 cents estimate, as payor mix and cost cuts boosted margins.

FibroGen sells its China unit to AstraZeneca for about $160M, strengthening its cash position and extending its financial runway into 2027. AstraZeneca gains full rights to roxadustat in China, while FibroGen retains US rights and plans an FDA meeting for next development steps.

The TUS+VEN+AZA triplet showed no dose-limiting toxicities in the first four patients, allowing escalation from 40 mg to 80 mg tuspetinib. Two FLT3-WT patients achieved complete remissions after Cycle 1, while another showed significant blast reduction and remains in therapy.

JP Morgan raises EQT price target to $58, citing strong 2025 outlook and potential conservative guidance. 2025 production forecast at 2,257 Bcfe with $2.2B FCF at $3.53/Mcf, aligning with company guidance. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, ...

Investors with a lot of money to spend have taken a bullish stance on Teck Resources TECK. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.